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Abstract 
Rothmund-Thomson syndrome (RTS) is a rare autosomal recessive disorder presenting with 
poikiloderma and other clinical features, affecting the bones and eyes and, in type II RTS, 
presenting an increased risk for malignancy. With about 300 cases reported so far, we pre-
sent a 13-year follow-up including clinical images, X-rays and genetic analysis. A 13-month-
old female started with a facial rash with blisters on her cheeks and limbs at the age of  
3 months along with congenital hypoplastic thumbs, frontal bossing and fine hair, eyebrows 
and eyelashes. The patient was lost to follow-up and returned 12 years later with palmoplan-
tar hyperkeratotic lesions, short stature, disseminated poikiloderma and sparse scalp hair, 
with absence of eyelashes and eyebrows. Radiographic analysis showed radial ray defect, ab-
sence of the thumb and three wrist carpal bones, and reduced bone density. Gene sequenc-
ing for the RECQL4 helicase gene revealed a mutation on each allele. RTS is a rare disease, 
and in this patient we observed the evolution of her skin lesions and other clinical features, 
which were important for the classification of type II RTS. The next years will provide even 
more information on this rare disease. © 2014 S. Karger AG, Basel 
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Introduction 
Rothmund-Thomson syndrome (RTS) is a rare autosomal recessive disorder. To date 
around 300 cases have been reported and two clinical forms have been described: type I, 
characterized by poikiloderma, ectodermal dysplasia and juvenile cataracts with unknown 
etiology, and type II with poikiloderma, congenital bone defects, an increased frequency of 
malignancy (specially osteosarcoma) and RECQL4 (8q24.3), the only gene whose mutations 
are known to cause RTS. It has yet to be clarified whether these two forms represent two 
different syndromes with common features or clinical entities involving different genes act-
ing on the same pathway [1]. 
Case Report 
We present a 13-month-old female with facial rash and blisters on the cheeks and limbs 
starting at the age of 3 months along with congenital hypoplastic thumbs, frontal bossing 
and fine hair, with thinning of brows and eyelashes. Skin biopsy showed epidermal atrophy 
with dermoepidermoid edema, and RTS was diagnosed (fig. 1). The patient returned 13 
years later with short stature, sparse scalp hair, absence of eyelashes and brows, dissemi-
nated poikiloderma, café au lait spots on the trunk and palmoplantar hyperkeratotic lesions. 
Radiographic analysis showed radial ray defect, absence of the thumb and three wrist carpal 
bones, and reduced bone density (fig. 2). No other alterations were found. Karyotype anal-
ysis was normal (46,XX). Gene sequencing revealed mutations in both alleles of the RECQL4 
helicase gene. One of them is a nonsense recurrent mutation located in exon 14, consisting of 
a change of a cytosine for a thymine (c.2269C>T) producing a premature stop codon and 
therefore a truncated protein (p.Q757X). On the other allele, the mutation observed has been 
described in few reports in a compound heterozygous state with c.2269C>T. This mutation  
is a deletion of two nucleotides found in exon 5 (c.1048_1049delAG) which produces a 
frameshift (p.Arg350Glyfs*21). 
Discussion 
RTS is a rare disease and because of its broad clinical spectrum, which includes some 
common features as well as some individual reports on clinical manifestations and abnor-
malities, patients can be easily misdiagnosed [2, 3]. This sheds light on the fact that this is  
a disease that is far from being completely described and understood. In this patient we 
observed the evolution of her skin lesions and other clinical features which, along with the 
mutations of the RECQL4 helicase gene, were important for the classification of type II RTS. 
In our patient, one of the mutations occurs in the domain of nuclear localization signal (ex-
tending from exon 5 through 8). The other mutation is located in the helicase domain encod-
ed by exons 8–14. Both findings are consistent with the literature, since nearly half of the 
mutations occur before or in the helicase domain, which is considered essential for the 
proper function of the protein, and represent nonsense, missplicing or frameshift mutations 
resulting in a truncated protein with impaired helicase activity [1, 4, 5]. 
Even though dermatologic screening and radiographic assessment were performed with 
no evidence of neoplastic disease, continual screening for malignancy is warranted due the 
high prevalence of osteosarcoma and skin cancer in these patients [1]. The follow-up for the 
next years will further improve our understanding of the disease. 
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Fig. 1. RTS. Thirteen-month-old patient showing poikiloderma on the face and extremities. 
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Fig. 2. RTS. Clinical features at the age of 13 years, including bone defects seen on X-ray. 
 
